FETAL-OUTCOME FOLLOWING INADVERTENT ADMINISTRATION OF LONG-ACTING DTRP6 GNRH MICROCAPSULES DURING PREGNANCY - A CASE-REPORT

被引：20

作者：

GOLAN, A

RONEL, R

HERMAN, A

WEINRAUB, Z

SOFFER, Y

CASPI, E

机构：

[1] Department of Obstetrics and Gynaecology, Assaf Harofe Medical Centre

来源：

HUMAN REPRODUCTION | 1990年 / 5卷 / 01期

关键词：

DTRP6 GnRH microcapsules; Pregnancy;

D O I：

10.1093/oxfordjournals.humrep.a137031

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Early follkular use of long-acting analogues of gonadotrophin releasing hormone (GnRH) in IVF programmes has caused some concern with respect to its teratogenic potential. In the case reported here, an injection of DTRP6 GnRH micro-capsules was given in the 5th week of a spontaneous unsuspected pregnancy. No deleterious effect or teratogenesis of the embryo could be demonstrated at birth or 18 months later. © 1990 Oxford University Press.

引用

页码：123 / 124

页数：2

共 7 条

[1]

Arimura A., Pedroza E., Vildex-Martinez J.A., Schally A.V., Prevention of implantation by D-Trp6 LH-RH in the rat: Comparative study with the effects of large doses of hCG on pregnancy, Endocr. Res. Commun, 4, (1977)

[2]

Casper R.F., Yen S.S., Induction of luteolysis in the human with long acting analog of luteinizing hormone-releasing factor, Science, (1979)

[3]

Happ J., Schultheiss H., Jacobi G.H., Wenderoth U.K., Buttenschon K., Miesel K., Sphan H., Hov G., Pharmacodynamics, pharmacokinetics and bioavailability of the prolonged LHRH agonist Decapeptyl-SR, Hormonal Manipulation of Cancer Monograph Series of the European Organization for Research on Treatment of Cancer, (1987)

[4]

Jeppsson S., Rannevik G., Studies on the gonadotropin response after administration of LH/FSH-releasing hormone (LRH) during pregnancy and after therapeutic abortion in the second trimester, Am, J. Obstet. Gynecol, 125, (1976)

[5]

Lemay A., Labrie F., Belanger A., Raynaud J.P., Luteolytic effect of intranasal administration of (D-Ser (TBU) 6, Des Gly- NHj)-luteinizing hormone ethylamide in normal women, Fertil. Steril, 32, (1979)

[6]

Serafim P., Batzofin J., Kerlin J., Marrs R., Pregnancy: A risk to initiation of leuprolide acetate during the luteal phase before controlled ovarian hyperstimulation, Fertil. Steril, 50, pp. 371-372, (1988)

[7]

Sopelak V.M., Hodgen G.D., Infusion of gonadotropin releasing hormone agonist during pregnancy: Maternal and fetal responses in primates, Am, J. Obstet. Gynecol, 156, (1987)

← 1 →